login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
PASSAGE BIO INC (PASG) Stock News
USA
- NASDAQ:PASG -
US7027122099
-
Common Stock
7.4
USD
-0.03 (-0.4%)
Last: 10/30/2025, 4:33:46 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
PASG Latest News, Press Relases and Analysis
All
Press Releases
17 days ago - By: Passage Bio
Passage Bio to Participate in Chardan’s 9th Annual Genetic Medicines Conference
17 days ago - By: Passage Bio
Passage Bio to Participate in Chardan’s 9th Annual Genetic Medicines Conference
2 months ago - By: Zacks Investment Research
Wall Street Analysts Think Passage Bio (PASG) Could Surge 731%: Read This Before Placing a Bet
2 months ago - By: Passage Bio
Passage Bio to Participate in H.C. Wainwright 27th Annual Global Investment Conference
2 months ago - By: Passage Bio
Passage Bio to Participate in H.C. Wainwright 27th Annual Global Investment Conference
3 months ago - By: Zacks Investment Research
Wall Street Analysts Believe Passage Bio (PASG) Could Rally 1415.15%: Here's is How to Trade
3 months ago - By: Benzinga
- Mentions:
PRPH
AZTR
FGEN
MYO
...
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
3 months ago - By: Passage Bio
Passage Bio Reports Second Quarter 2025 Financial Results and Provides Recent Business Highlights
3 months ago - By: Passage Bio
Passage Bio Reports Second Quarter 2025 Financial Results and Provides Recent Business Highlights
3 months ago - By: Benzinga
- Mentions:
IVA
PIII
TTNP
HCTI
...
12 Health Care Stocks Moving In Friday's Intraday Session
4 months ago - By: Passage Bio
Passage Bio Announces 1-for-20 Reverse Stock Split
4 months ago - By: Passage Bio
Passage Bio Announces 1-for-20 Reverse Stock Split
4 months ago - By: Passage Bio
Passage Bio Reports Updated Interim Data from upliFT-D Study and Provides Program Update
4 months ago - By: Passage Bio
Passage Bio Reports Updated Interim Data from upliFT-D Study and Provides Program Update
6 months ago - By: Passage Bio
Passage Bio Reports First Quarter 2025 Financial Results and Provides Recent Business Highlights
6 months ago - By: Passage Bio
Passage Bio Reports First Quarter 2025 Financial Results and Provides Recent Business Highlights
8 months ago - By: Passage Bio
Passage Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent Business Highlights
8 months ago - By: Passage Bio
Passage Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent Business Highlights
8 months ago - By: Passage Bio
Passage Bio to Participate in Upcoming Investor Conferences
8 months ago - By: Passage Bio
Passage Bio to Participate in Upcoming Investor Conferences
10 months ago - By: Passage Bio
Passage Bio Announces Interim Data from upliFT-D Study in FTD-GRN and Provides Business Updates
a year ago - By: Passage Bio
Passage Bio Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights
a year ago - By: Passage Bio
Passage Bio Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights
a year ago - By: Passage Bio
Passage Bio to Present at Guggenheim Securities Healthcare Innovation Conference
a year ago - By: Passage Bio
Passage Bio to Present at Guggenheim Securities Healthcare Innovation Conference
a year ago - By: Passage Bio
Passage Bio Presents Preclinical and Interim Clinical Data for PBFT02 in FTD-GRN at the European Society of Gene & Cell Therapy (ESGCT) 31st Annual Conference
Please enable JavaScript to continue using this application.